Tufts University School of Medicine, in Boston, Massachusetts, Baystate Medical Center, Springfield, Massachusetts, USA.
Health Aff (Millwood). 2010 Aug;29(8):1523-31. doi: 10.1377/hlthaff.2009.0287.
As rapid U.S. health care spending growth continues, the question of whether additional dollars purchase better health or unnecessary care remains in sharp focus for policy makers, large employers, and other stakeholders. To investigate this question, we measured changes in mortality and cost for seven common diagnoses at 122 U.S. hospitals from 2000 to 2004. After adjusting for inflation, we found little correlation between reduced mortality for certain conditions and increased spending on patients with those conditions. The message to be underscored once again for policy makers is that health care dollars provide inconsistent value, and future spending increases should be targeted to care that improves outcomes.
随着美国医疗保健支出的快速增长，政策制定者、大雇主和其他利益相关者仍然高度关注这些额外的资金是否能带来更好的健康或不必要的医疗服务。为了研究这个问题，我们对 2000 年至 2004 年间美国 122 家医院的 7 种常见诊断的死亡率和成本变化进行了测量。经通胀调整后，我们发现某些疾病的死亡率降低与这些疾病患者的支出增加之间几乎没有相关性。对于政策制定者来说，这一信息需要再次强调，即医疗保健支出的价值并不一致，未来的支出增长应该针对改善结果的医疗服务。
